NCT07433777

Brief Summary

Reference intervals are an essential tool for the clinical interpretation of laboratory test results. Traditionally, these interval are determined using samples from healthy individuals, a process that is resource-intensive, time-consuming, and require the active recruitment of healthy volunteers. In recent years, due to the increasing availability of electronic health record (EHR) databases and the growing number of laboratory tests, it is possible to determine the reference intervals indirectly. This approach relies on the analysis of routine data acquired in clinical laboratories, eliminating the need for active recruiting healthy subjects and significantly reducing costs. Moreover, the method has the potential to eliminate the selection bias of an ultra-healthy population typical of the direct methods. The indirect methods for determining reference intervals have evolved from simple strategies of isolating the healthy population using sample metadata, to sophisticated statistical models that effectively distinguish normal from pathological distributions. One of the advanced techniques, RefineR, has reached an excellent combination of accuracy, robustness, and computational efficiency, outperforming previous methods. It has been implemented as an open-source R package, facilitating its application in real-world settings. In recognition of these advantages, the IFCC (International Federation of Clinical Chemistry and Laboratory Medicine), through its Committee on Reference Intervals and Decision Limits (C-RIDL), has promoted the adoption of indirect methods for determining reference intervals, highlighting the advantages of this strategy, including greater speed, lower costs, and the absence of a need to recruit healthy donors. Furthermore, a recent study has highlighted age-related physiological variations in hemoglobin levels in elderly population. This underscores the need for defining age-specific reference intervals which are currently absent from most laboratory reports, potentially impacting diagnostic accuracy.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,000,000

participants targeted

Target at P75+ for all trials

Timeline
22mo left

Started Oct 2025

Typical duration for all trials

Geographic Reach
1 country

24 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress31%
Oct 2025Jun 2028

Study Start

First participant enrolled

October 8, 2025

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

February 19, 2026

Completed
6 days until next milestone

First Posted

Study publicly available on registry

February 25, 2026

Completed
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2028

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2028

Last Updated

February 25, 2026

Status Verified

February 1, 2026

Enrollment Period

2.6 years

First QC Date

February 19, 2026

Last Update Submit

February 19, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Define indirect reference intervals for complete blood count (CBC) parameters by analyzing large-scale retrospective routine laboratory data.

    up to 3 years

Secondary Outcomes (3)

  • Assess regional differences by comparing results across 10 Italian regions.

    up to 3 years

  • Establish age- and sex-specific reference intervals

    up to 3 years

  • Evaluate inter-instrument variations by considering results obtained from different analytical platforms.

    up to 3 years

Eligibility Criteria

Age0 Years - 100 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The study population consists of all patients undergoing routine laboratory testing during the year 2024 at the participating centers.

You may qualify if:

  • no one

You may not qualify if:

  • no one

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (24)

ASL Bari, Ospedale della Murgia, Altamura

Altamura, Altamura, Italy

NOT YET RECRUITING

Azienda Ospedaliero-Universitaria Ospedali Riuniti di Ancona

Ancona, Ancona, Italy

NOT YET RECRUITING

Azienda USL Toscana Sud Est, Arezzo

Arezzo, Arezzo, Italy

NOT YET RECRUITING

Azienda ULSS 1 Dolomiti

Belluno, Belluno, Italy

NOT YET RECRUITING

Azienda Ospedaliero-Universitaria Careggi, Firenze

Florence, Firenze, Italy

NOT YET RECRUITING

IRCCS Istituto Clinico Humanitas, Milano

Milan, Milano, Italy

NOT YET RECRUITING

IRCCS Ospedale San Raffaele, Milano

Milan, Milano, Italy

NOT YET RECRUITING

Azienda Ospedaliero-Universitaria di Modena

Modena, Modena, Italy

NOT YET RECRUITING

Bianalisi Carate Brianza, Monza e Brianza

Monza, Monza, Italy

NOT YET RECRUITING

Azienda Ospedaliero-Universitaria Maggiore della Carità di Novara

Novara, Novara, Italy

NOT YET RECRUITING

Azienda Ospedale Università Padova

Padua, Padova, Italy

NOT YET RECRUITING

Azienda Ospedaliera Universitaria Policlinico 'Paolo Giaccone' di Palermo

Palermo, Palermo, Italy

NOT YET RECRUITING

Centro di Riferimento Oncolgico -IRCCS

Aviano, Pordenone, 33081, Italy

RECRUITING

Azienda Sanitaria Friuli Occidentale, Ospedale di Pordenone

Pordenone, Pordenone, Italy

NOT YET RECRUITING

Azienda Ospedaliera Universitaria Senese,

Siena, Siena, Italy

NOT YET RECRUITING

Azienda Sanitaria Universitaria Giuliano Isontina

Trieste, Trieste, Italy

NOT YET RECRUITING

Azienda Sanitaria Universitaria Friuli Centrale, Ospedale di Udine

Udine, Udine, Italy

NOT YET RECRUITING

AULSS 3 Serenissima, Ospedale di Mestre

Mestre, Venezia, Italy

NOT YET RECRUITING

Azienda Ospedaliera Universitaria Integrata di Verona

Verona, Verona, Italy

NOT YET RECRUITING

AULSS 8 Berica, Ospedale S. Bortolo di Vicenza

Vicenza, Vicenza, Italy

NOT YET RECRUITING

Ospedale di Desio, ASST Brianza

Desio, Italy

NOT YET RECRUITING

ASL5 Spezzino, La Spezia

La Spezia, Italy

NOT YET RECRUITING

ASST Grande Ospedale Metropolitano Niguarda, Milano

Milan, Italy

NOT YET RECRUITING

Azienda ULSS 2 Marca Trevigiana

Treviso, Italy

NOT YET RECRUITING

Central Study Contacts

Fabio Del Ben

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 19, 2026

First Posted

February 25, 2026

Study Start

October 8, 2025

Primary Completion (Estimated)

June 1, 2028

Study Completion (Estimated)

June 1, 2028

Last Updated

February 25, 2026

Record last verified: 2026-02

Locations